Mika Mizuno

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman, Gini F. Fleming, Mark F. Brady et al. · New England Journal of Medicine · 2019 · 886 citations · Full text

Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary

Mika Mizuno, Fumitaka Kikkawa, Kiyosumi Shibata et al. · Journal of Surgical Oncology · 2006 · 101 citations

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9

Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study

Mitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda et al. · Gynecologic Oncology · 2017 · 73 citations

Prognostic Factors, Optimal Therapy, Endocrine Oncology +8

Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery

Hiroaki Kajiyama, Kiyosumi Shibata, Mika Mizuno et al. · British Journal of Cancer · 2011 · 69 citations · Full text